In the adriamycin-induced mouse model of nephropathy, researchers found that CCL2 in the kidney may recruit the infiltration of inflammatory and pro-fibrotic bone marrow-derived cell populations through its receptor CCR2; furthermore, a deficiency of Ccr2 in mice can ameliorate renal injury (17). Here, CCR2 is linked to kidney disorder.